drugset / Trial / NCT00770900
Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)
RandomizedParallel-groupDouble-blindTreatment
Summary
Verify if the quantitative parameters of the eosinophils activation and phagocyte system function show a predictive value for clinical response and prognostic in patients with persistent asthma treated with montelukast
Timeline
- Start
- 2008-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 4 mg | — |
| Subject | Montelukast | Other / unclassified | 5 mg | — |
| Subject | Montelukast | Other / unclassified | 10 mg | — |